Evidence map›Paper›PMID 41171997›Full record

Trial reportJMIR formative research2025

Feasibility and Acceptability of a mHealth Patient Navigation Intervention to Increase Pre-Exposure Prophylaxis Uptake in Racially and Ethnically Diverse Sexual and Gender Minority Youth in Los Angeles (PrEPresent): Pilot Randomized Controlled Trial.

Sam Calvetti, Bryan Lei, Jacob B Stocks, Matthew T Rosso, Manuel Puentes, Ramon Durazo-Arvizu, Lindsay Slay, Michele D Kipke, Lisa B Hightow-Weidman

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in JMIR formative research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sam CalvettiPediatric Research Administration, Children's Hospital Los Angeles, 4650 Sunset Boulevard, Los Angeles, CA, 90027, United States, 1 3236602450.ORCID 0000-0003-1741-4640
Bryan LeiBiostatistics and Data Management Core, The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, United States.ORCID 0009-0005-1591-968X
Jacob B StocksInstitute on Digital Health and Innovation, College of Nursing, Florida State University, Tallahassee, FL, United States.ORCID 0000-0003-3067-4324
Matthew T RossoInstitute on Digital Health and Innovation, College of Nursing, Florida State University, Tallahassee, FL, United States.ORCID 0000-0003-0297-758X
Manuel PuentesPediatric Research Administration, Children's Hospital Los Angeles, 4650 Sunset Boulevard, Los Angeles, CA, 90027, United States, 1 3236602450.ORCID 0009-0004-3697-7822
Ramon Durazo-ArvizuBiostatistics and Data Management Core, The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, United States.ORCID 0000-0001-6563-7107
Lindsay SlayPediatric Research Administration, Children's Hospital Los Angeles, 4650 Sunset Boulevard, Los Angeles, CA, 90027, United States, 1 3236602450.ORCID 0000-0002-8122-967X
Michele D KipkePediatric Research Administration, Children's Hospital Los Angeles, 4650 Sunset Boulevard, Los Angeles, CA, 90027, United States, 1 3236602450.ORCID 0000-0002-1032-2324
Lisa B Hightow-WeidmanInstitute on Digital Health and Innovation, College of Nursing, Florida State University, Tallahassee, FL, United States.ORCID 0000-0002-2421-923X

Funding

Southern California Clinical and Translational Science InstituteUL1TR001855 · NCATS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Thomas A Buchanan, Michele D. Kipke · 2016 to 2026
$81.3M
Southern California Clinical and Translational Science InstituteUL1TR000130 · NCATS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BUCHANAN, THOMAS A · 2012 to 2015
$36.0M
PrEP2Prevent: An Online PrEP Navigation and Activation Intervention for YMSMR34DA050531 · NIDA · CHILDREN'S HOSPITAL OF LOS ANGELES · PI HIGHTOW-WEIDMAN, LISA B, KIPKE, MICHELE D. · 2020 to 2022
$756k
NCATS NIH HHS UL1 TR000130NCATS NIH HHS UL1 TR001855NIDA NIH HHS R34 DA050531
6 · The paper itself

Abstract

Background: Pre-exposure prophylaxis (PrEP) is a powerful tool to prevent the transmission of HIV. Interventions promoting PrEP must focus on populations most impacted by systemic barriers to uptake. Historically, young sexual minority men and transgender women have the highest demonstrated rates of new HIV diagnoses, but prevalence within other gender minority populations is now being studied. Few interventions have focused on addressing PrEP uptake with sexual and gender minority (SGM) youth, particularly through mobile health (mHealth) technologies. Built on the successful foundation of the HealthMpowerment Platform, PrEPresent aimed to engage SGM youth across diverse gender, racial, and ethnic identities in the Greater Los Angeles area. Objective: The aim of this study was to evaluate the feasibility and acceptability of a digital peer patient-navigation PrEP uptake app. Methods: PrEPresent incorporated patient activation theory into an mHealth intervention. The study took place over a 6-month period with visits at baseline, 3 months, and 6 months. The intervention period lasted from baseline to 3 months. Control participants received an information-only app. Intervention participants received an enhanced app and access to an interventionist, the PrEPresentative. Intervention participants could meet with the PrEPresentative four times over the 3-month period via phone, Health Insurance Portability and Accountability Act-compliant videoconferencing, or an in-app text messaging. PrEP uptake was measured through survey responses and the UrSure rapid urine test of tenofovir. Results: PrEPresent comprised of 147 sexual and gender-diverse participants-75 participants were randomized into the control arm and 72 into the intervention arm. A total of 48% (71/147) were Latinx and 18% (27/147) were Black or African American. Most (98/147, 67%) were transgender or gender diverse, and the remaining (49/147, 33%) were cisgender men. PrEP was initiated by 25% (14/56) of intervention participants and 19% (11/58) of control participants. In total, 50% (36/72) of intervention participants completed two or more sessions with the interventionist. Intervention participants had an average of 15.93 (SD 15.85) logins compared to 6.31 (SD 9.27) logins for control participants. Average use of the mHealth platform was 9.51 (SD 11.47) minutes for intervention participants and 3.03 (SD 5.70) minutes for control participants. Conclusions: PrEPresent met primary outcome measures of feasibility and acceptability. Despite this, PrEP uptake was low, and use of the platform was low compared to other HealthMpowerment projects. While mHealth offers promising HIV prevention outcomes, fostering active app engagement is crucial in promoting behavior change. Mixed success in initiating PrEP uptake across mHealth interventions involving SGM youth warrants further inquiry into how these platforms can address prevention barriers with this population. Interventions targeting uptake and adherence will need to adapt as the landscape of PrEP delivery evolves with the adoption of on-demand and long-acting injectable modalities.

Indexed as

HIV InfectionsPatient Acceptance of Health CarePre-Exposure ProphylaxisSexual and Gender MinoritiesAdolescentAdultEthnicityFeasibility StudiesFemaleHumansLos AngelesMaleMobile ApplicationsPilot ProjectsRacial GroupsTelemedicineadolescentHIVLGBTQmobile healthpre-exposure prophylaxisPrEPtransgender

Identifiers

PMID41171997
PMCPMC12577774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.